Journal of Medicinal Chemistry
Article
(24) Wouters, M. M.; Roeder, J. L.; Tharayil, V. S.; Stanich, J. E.;
Strege, P. R.; Lei, S.; Bardsley, M. R.; Ordog, T.; Gibbons, S. J.;
Farrugia, G. Protein kinase Cγ mediates regulation of proliferation by
the serotonin 5-hydroxytryptamine receptor 2B. J. Biol. Chem. 2009,
284, 21177−21184.
(25) Chen, Y.; Li, Z.; Yang, Y.; Lin, L.; Zhang, H. Effect of 5-HT2B
receptor on the pathogenetic mechanism of irritable bowel syndrome
subgroups in rat models. Acta Univ. Med. Nanjing 2012, 32, 609−615.
(26) Bassil, A.; Taylor, C.; Bolton, V.; Gray, K.; Brown, J.; Cutler, L.;
Summerfield, S.; Bruton, G.; Winchester, W.; Lee, K.; Sanger, G. J.
Inhibition of colonic motility and defecation by RS-127445 suggests an
involvement of the 5-HT2B receptor in rodent large bowel physiology.
Br. J. Pharmacol. 2009, 158, 252−258.
(27) O’mahony, S.; Bulmer, D.; Coelho, A.; Fitzgerald, P.;
Bongiovanni, C.; Lee, K.; Winchester, W.; Dinan, T.; Cryan, J. 5-
HT2B receptors modulate visceral hypersensitivity in a stress-sensitive
animal model of brain-gut axis dysfunction. Neurogastroenterol. Motil.
2010, 22, 573−e124.
(28) Ohashi-doi, K.; Himaki, D.; Nagao, K.; Kawai, M.; Gale, J.;
Furness, J.; Kurebayashi, Y. A selective, high affinity 5-HT2B receptor
antagonist inhibits visceral hypersensitivity in rats. Neurogastroenterol.
Motil. 2010, 22, e69−e76.
(29) Takahashi, N.; Inagaki, K.; Taniguchi, K.; Sakaguchi, Y.;
Kawamura, K. The novel 5-HT2B receptor antagonist, RQ-00310941,
attenuates visceral hypersensitivity and abnormal defecation in rat
models. Gastroenterology 2011, 140, S−607.
(30) Poissonnet, G.; Parmentier, J. G.; Boutin, J. A.; Goldstein, S.
The emergence of selective 5-HT2B antagonists structures, activities
and potential therapeutic applications. Mini-Rev. Med. Chem. 2004, 4,
325−330.
(31) Lin, X.; Huang, X.-P.; Chen, G.; Whaley, R.; Peng, S.; Wang, Y.;
Zhang, G.; Wang, S. X.; Wang, S.; Roth, B. L.; Huang, N. Life beyond
kinases: Structure-based discovery of sorafenib as nanomolar
antagonist of 5-HT receptors. J. Med. Chem. 2012, 55, 5749−5759.
(32) Cusack, B.; Nelson, A.; Richelson, E. Binding of antidepressants
to human brain receptors: Focus on newer generation compounds.
Psychopharmacology (Berl) 1994, 114, 559−565.
(42) Al-Chaer, E. D.; Kawasaki, M.; Pasricha, P. J. A new model of
chronic visceral hypersensitivity in adult rats induced by colon
irritation during postnatal development. Gastroenterology 2000, 119,
1276−1285.
(43) Jacobson, M. A.; Kaminski, G. A.; Friesner, G. A.; Rapp, C. S.
Force field validation using protein side chain prediction. J. Phys.
Chem. B 2002, 106, 11673−11680.
(44) Jacobson, M. P.; Pincus, D. L.; Rapp, C. S.; Day, T. J.; Honig, B.;
Shaw, D. E.; Friesner, R. A. A hierarchical approach to all-atom protein
loop prediction. Proteins: Struct., Funct., Genet. 2004, 55, 351−367.
(45) Li, X.; Jacobson, M. P.; Friesner, R. A. High-resolution
prediction of protein helix positions and orientations. Proteins: Struct.,
Funct., Genet. 2004, 55, 368−382.
(46) Van Der Spoel, D.; Lindahl, E.; Hess, B.; Groenhof, G.; Mark, A.
E.; Berendsen, H. J. GROMACS: fast, flexible, and free. J. Comput.
Chem. 2005, 26, 1701−1718.
(47) Hornak, V.; Abel, R.; Okur, A.; Strockbine, B.; Roitberg, A.;
Simmerling, C. Comparison of multiple Amber force fields and
development of improved protein backbone parameters. Proteins:
Struct., Funct., Genet. 2006, 65, 712−725.
(48) Jorgensen, W. L.; Chandrasekhar, J.; Madura, J. D.; Impey, R.
W.; Klein, M. L. Comparison of simple potential functions for
simulating liquid water. J. Chem. Phys. 1983, 79, 926−935.
(49) Sciortino, F.; Essmann, U.; Stanley, H. E.; Hemmati, M.; Shao,
J.; Wolf, G. H.; Angell, C. A. Crystal stability limits at positive and
negative pressures, and crystal-to-glass transitions. Phys. Rev. E: Stat.
Phys., Plasmas, Fluids, Relat. Interdiscip. Top. 1995, 52, 6484−6491.
(50) Hess, B.; Bekker, H.; Berendsen, H. J. C.; Fraaije, J. LINCS: A
linear constraint solver for molecular simulations. J. Comput. Chem.
1997, 18, 1463−1472.
(51) Okuno, Y.; Yang, J.; Taneishi, K.; Yabuuchi, H.; Tsujimoto, G.
GLIDA: GPCR-ligand database for chemical genomic drug discovery.
Nucleic Acids Res. 2006, 34, D673−D677.
(52) Okuno, Y.; Tamon, A.; Yabuuchi, H.; Niijima, S.; Minowa, Y.;
Tonomura, K.; Kunimoto, R.; Feng, C. GLIDA: GPCRligand
database for chemical genomics drug discoverydatabase and tools
update. Nucleic Acids Res. 2008, 36, D907−D912.
(33) Shimamura, T.; Shiroishi, M.; Weyand, S.; Tsujimoto, H.;
Winter, G.; Katritch, V.; Abagyan, R.; Cherezov, V.; Liu, W.; Han, G.
W.; Kobayashi, T.; Stevens, R. C.; Iwata, S. Structure of the human
histamine H1 receptor complex with doxepin. Nature 2011, 475, 65−
70.
(34) Warne, T.; Edwards, P. C.; Leslie, A. G.; Tate, C. G. Crystal
structures of a stabilized beta1-adrenoceptor bound to the biased
agonists bucindolol and carvedilol. Structure 2012, 20, 841−849.
(35) Sun, H.; Zhao, L.; Peng, S.; Huang, N. Incorporating
replacement free energy of binding-site waters in molecular docking.
Proteins: Struct., Funct., Genet. 2014, 82, 1765−1776.
(36) Huang, N.; Kalyanaraman, C.; Irwin, J. J.; Jacobson, M. P.
Physics-based scoring of protein−ligand complexes: Enrichment of
known inhibitors in large-scale virtual screening. J. Chem. Inf. Model.
2006, 46, 243−253.
(37) Cao, R.; Liu, M.; Yin, M.; Liu, Q.; Wang, Y.; Huang, N.
Discovery of novel tubulin inhibitors via structure-based hierarchical
virtual screening. J. Chem. Inf. Model. 2012, 52, 2730−2740.
(38) Keiser, M. J.; Roth, B. L.; Armbruster, B. N.; Ernsberger, P.;
Irwin, J. J.; Shoichet, B. K. Relating protein pharmacology by ligand
chemistry. Nat. Biotechnol. 2007, 25, 197−206.
(53) Bemis, G. W.; Murcko, M. A. The properties of known drugs. 1.
Molecular frameworks. J. Med. Chem. 1996, 39, 2887−2893.
(54) Mysinger, M. M.; Carchia, M.; Irwin, J. J.; Shoichet, B. K.
Directory of useful decoys, enhanced (DUD-E): Better ligands and
decoys for better benchmarking. J. Med. Chem. 2012, 55, 6582−6594.
(55) Huang, N.; Shoichet, B. K.; Irwin, J. J. Benchmarking sets for
molecular docking. J. Med. Chem. 2006, 49, 6789−6801.
(56) Wei, B. Q.; Baase, W. A.; Weaver, L. H.; Matthews, B. W.;
Shoichet, B. K. A model binding site for testing scoring functions in
molecular docking. J. Mol. Biol. 2002, 322, 339−355.
(57) Lorber, D. M.; Shoichet, B. K. Hierarchical docking of databases
of multiple ligand conformations. Curr. Top. Med. Chem. 2005, 5,
739−749.
(58) Ferrin, T. E.; Huang, C. C.; Jarvis, L. E.; Langridge, R. The
MIDAS display system. J. Mol. Graphics 1988, 6, 13−27.
(59) Kuntz, I. D.; Blaney, J. M.; Oatley, S. J.; Langridge, R.; Ferrin, T.
E. A geometric approach to macromolecule-ligand interactions. J. Mol.
Biol. 1982, 161, 269−288.
(60) Mysinger, M. M.; Shoichet, B. K. Rapid context-dependent
ligand desolvation in molecular docking. J. Chem. Inf. Model. 2010, 50,
1561−1573.
(39) Yuthavong, Y.; Tarnchompoo, B.; Vilaivan, T.; Chitnumsub, P.;
Kamchonwongpaisan, S.; Charman, S. A.; McLennan, D. N.; White, K.
L.; Vivas, L.; Bongard, E.; et al. Malarial dihydrofolate reductase as a
paradigm for drug development against a resistance-compromised
target. Proc. Natl. Acad. Sci. U. S. A. 2012, 109, 16823−16828.
(40) Wan, X.; Zhang, W.; Li, L.; Xie, Y.; Li, W.; Huang, N. A new
target for an old drug: Identifying mitoxantrone as a nanomolar
inhibitor of PIM1 kinase via kinome-wide selectivity modeling. J. Med.
Chem. 2013, 56, 2619−2629.
(61) Nicholls, A.; Honig, B. A rapid finite difference algorithm,
utilizing successive over-relaxation to solve the Poisson-Boltzmann
equation. J. Comput. Chem. 1991, 12, 435−445.
(62) Irwin, J. J.; Shoichet, B. K. ZINC-a free database of
commercially available compounds for virtual screening. J. Chem. Inf.
Model. 2005, 45, 177−182.
(63) Irwin, J. J.; Sterling, T.; Mysinger, M. M.; Bolstad, E. S.;
Coleman, R. G. ZINC: A free tool to discover chemistry for biology. J.
Chem. Inf. Model. 2012, 52, 1757−1768.
(64) Jorgensen, W. L.; Maxwell, D. S.; Tirado-Rives, J. Development
and testing of the OPLS all-atom force field on conformational
(41) McCorvy, J. D.; Roth, B. L. Structure and function of serotonin
G protein-coupled receptors. Pharmacol. Ther. 2015, 150, 129−142.
M
J. Med. Chem. XXXX, XXX, XXX−XXX